Doctor Says Drug Maker Tried to Quash His Criticism of Avandia

Jeremy Thurman
Attorney
(866) 735-1102 Ext 412
Posted by Jeremy ThurmanJune 04, 2007 2:50 PM

The New York Times just had an article about the Drug Avandia. It states that a Congressional committee hearing next Wednesday will try to determine whether federal regulators paid sufficient attention to potential risks of the diabetes drug Avandia. One witness, scheduled to appear at the hearing, claims that Avandia's maker, GlaxoSmithKline, attempted to silence his criticism of the drug. John B. Buse, a nationally recognized diabetes specialist, says that Glaxo engaged in tactics to intimidate the doctor to keep him from going public with his concerns.

http://www.nytimes.com/2007/06/02/business/02drug.html?ref=health

0 Comments

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

Comments for this article are closed.

Subscribe to InjuryBoard Oklahoma City

InjuryBoard Oklahoma City RSS Feeds

Keep up with the latest updates using your favorite RSS reader

Injury Board Oklahoma City is brought to you by McIntyre Law

Legal Assistance Center

More Info
McIntyre Law (866) 735-1102 Ext 410
google
Personal Injury Lawyers Serving: Oklahoma City, Tulsa, Stillwater, Norman, Bartlesville, Broken Arrow, Duncan, Edmond, Enid, Lawton, Midwest City, Moore, Muskogee, Ponca City, Shawnee, Ardmore
1300 S. MeridianSuite 501, Oklahoma City, Oklahoma 73108 [ Show Map ]
Better Business Bureau Accredited Business Confidential

Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.

Looking for an InjuryBoard attorney closer to home? Click here.

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address